Status:
COMPLETED
Oral Contraceptive Consumption Timing and Cognition and Metabolism
Lead Sponsor:
University of Lincoln
Conditions:
Cognitive Change
Eligibility:
FEMALE
18-35 years
Phase:
NA
Brief Summary
The aim of this randomised-controlled trial is to examine whether the timing of oral contraceptive administration affects cognitive function, substrate metabolism and exercise performance. Participan...
Detailed Description
Reproductive hormones, such as oestrogen and progesterone, are known to affect cognitive function (i.e. thinking, learning and processing information) and substrate metabolism (i.e. how the body uses ...
Eligibility Criteria
Inclusion
- Female
- Aged 18-35 years
- The use of the same oral contraceptive (30 micrograms ethinyl estradiol and 150mg levonorgestrel) for at least 6 months
- Physically active and able to take part in treadmill-based exercise
- Speak fluent English
Exclusion
- Use of any other type of hormonal contraception
- Aged \< 18 or \> 35 years
- Poly-cystic ovarian syndrome
- Endometriosis
- Pregnant
- Child birth or lactation in the previous 6 months
- Body mass index \< 18.5 or \> 30 kg.m2
- Any disorder known to affect metabolic health
- History of head injury/neurological disorders
- Use of any steroid-based medication or medications known to influence the central nervous system
- History of psychiatric disorders such as major depression or an anxiety disorder
- Smokers
- Suffer from (or have suffered from) a heart complaint
- Advised by medical professional to refrain from high intensity exercise
- Current muscle or joint injury
Key Trial Info
Start Date :
January 17 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 20 2024
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT06560944
Start Date
January 17 2020
End Date
January 20 2024
Last Update
August 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dan Martin
Lincoln, Lincolnshire, United Kingdom, LN6 7TS